Patients with inflammatory bowel disease (IBD) and high visceral adipose tissue (VAT) may have more difficulty achieving higher infliximab levels necessary to achieve remission, according to a study published in the November ...
Nov 15, 2023
0
0
For patients with inflammatory bowel disease (IBD), monitoring by intestinal ultrasound (IUS) results in reduced time to treatment change and to remission, according to a study presented at the annual meeting of the American ...
Oct 25, 2023
0
2
A financial assistance program (FAP) improves outcomes for indigent patients with inflammatory bowel disease (IBD), according to a study recently published in Pathophysiology.
Dec 12, 2022
0
20
New research presented this week at ACR Convergence 2022, the American College of Rheumatology's annual meeting, demonstrated that polyarticular juvenile idiopathic arthritis patients were more likely to achieve clinical ...
Nov 8, 2022
0
0
Three novel fecal biomarkers have been identified for inflammatory bowel disease (IBD), according to a study published online Aug. 30 in the Journal of Crohn's & Colitis.
Sep 20, 2022
0
22
PsA is a type of inflammatory arthritis linked to psoriasis—a chronic condition affecting the skin and nails. People with PsA experience pain and swelling in their joints, and at the points where tendons and ligaments attach ...
Jun 4, 2022
0
1
Avacopan was better than prednisone in reducing respiratory as well as ear, nose and throat (ENT) involvement in ANCA-associated vasculitis patients participating in the phase 3 ADVOCATE trial, and enabled reduced glucocorticoid ...
May 18, 2022
0
9
A combination of ibrutinib and venetoclax was found to provide lasting disease remission in patients with newly diagnosed chronic lymphocytic leukemia (CLL), according to researchers at The University of Texas MD Anderson ...
Jun 10, 2021
0
4
(HealthDay)—Low disease activity and remission are feasible goals for women with rheumatoid arthritis (RA) cared for with a modern treatment approach during pregnancy, according to a study published online Feb. 10 in the ...
Feb 25, 2021
0
3
Tofacitinib, a Janus kinase inhibitor approved to treat rheumatoid arthritis and bowel diseases, may allow patients with celiac disease to eat gluten without experiencing intestinal and extraintestinal symptoms. A case report ...
Jul 28, 2020
0
4
